Dova Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch DOVA and buy or sell other stocks, ETFs, and their options commission-free!

About DOVA

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count.

CEO

David S. Zaccardelli, PharmD

CEODavid S. Zaccardelli, PharmD

Employees

—

Employees—

Headquarters

Durham, North Carolina

HeadquartersDurham, North Carolina

Founded

2016

Founded2016

Employees

—

Employees—

DOVA Key Statistics

Market cap

807.61M

Market cap807.61M

Price-Earnings ratio

-10.95

Price-Earnings ratio-10.95

Dividend yield

—

Dividend yield—

Average volume

773.13K

Average volume773.13K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$28.54

52 Week high$28.54

52 Week low

$5.62

52 Week low$5.62

Dova Pharmaceuticals

Why Robinhood?

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Show more

DOVA Key Statistics

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count.